Neutralite SR Page 1 of 10
SAFETY DATA SHEET
Revision Date: June 2, 2017
Supersedes: June 24, 2008
1.
PRODUCT AND
COMPANY IDENTIFICATION
Trade Name:
Chemical Name:
Synonyms:
Formula:
Product Use:
Neutralite SR
Complex Alumino-Silicates
None
Mixture
Conditioning agent for fabric filters in air
pollution control equipment
COMPANY ADDRESS
BHA Altair, LLC
11501 Outlook Street
Suite 100
Overland Park, KS 66211
TECHNICAL INFORMATION:
816-356-8400
TRANSPORTATION
EMERGENCY:
CHEMTREC (800) 424-9300
2.
HAZARDS IDENTIFICATION
May cause eye, skin and respiratory tract irritation. May cause gastrointestinal mucosal irritation.
Long-term exposure may cause drying and cracking of the skin or dermatitis, conjunctivitis, or irritation
of tissues and mucous membranes of the respiratory system. Prolonged and repeated exposure to
excessive concentrations of this product, or any nuisance dust, can cause chronic pulmonary disease.
Avoid breathing dust. Use and store with adequate ventilation.
Regulation (EC) No 1272/2008 Classification
Pictogram
Classification
Signal Word and Hazard Statements
None
None
None
GHS/CLP Precautionary Statements†
Prevention: None
Response:
None
Storage:
None
Disposal:
None
†
See Section 16 for definition of Precautionary Statements.
POTENTIAL HEALTH EFFECTS
EYE:
May cause mild to moderate eye irritation with tearing and redness of
eyes and associated tissues and membranes.
SKIN:
Continuous contact will result in drying and mild irritation due to
removal of natural moisture and oils.
INHALATION:
May cause mild respiratory tract irritation and drying of mucous
membranes and associated respiratory tract tissues. Sneezing and
Revision Date: June 2, 2017
Neutralite SR Page 2 of 10
occasional cough may occur.
2.
HAZARDS IDENTIFICATION (CONT’D)
INGESTION:
May cause dryness of mouth and throat and mild irritation of affected
tissues.
MEDICAL CONDITIONS
AGGRAVATED BY
EXPOSURE:
Individuals with pre-existing lung, eye or skin disorders may have
increased susceptibility aggravated by the effects of overexposure.
CHRONIC EFFECTS:
May cause dryness, cracking, mild skin irritation and/or dermatitis with
continuous contact due to the removal of natural moisture and oils.
Prolonged or repeated eye contact may cause conjunctivitis.
Prolonged or repeated exposures may result in overcharging the
respiratory system leading to irritation of tissues and mucous
membranes. Prolonged and repeated exposure to excessive
concentrations of this product, or any nuisance dust, can cause
chronic pulmonary disease.
POTENTIAL
ENVIRONMENTAL EFFECTS
3.
None known.
COMPOSITION/INFORMATION ON INGREDIENTS
Components
Complex Alumino-Silicates*
Alkaline Earth Metal Hydroxide
*
CAS Number
% by Weight
Proprietary
60-100%
Proprietary
1 – 5%
*
Neutralite SR is a proprietary blend of components. Information released shall be governed under the
trade secret protection standards as outlined in 29 CFR 1910.1200.
4.
FIRST AID MEASURES
PROCEDURES
EYE CONTACT:
In case of contact, flush eyes with plenty of water for at least 15
minutes, lifting upper and lower lids occasionally. Remove person
away from source of exposure and to fresh air. If irritation persists,
get medical attention.
SKIN CONTACT:
In case of contact, wash skin with mild soap and plenty of water.
Remove contaminated clothing and shoes and launder before reuse.
Apply body lotion to affected areas to rejuvenate moisture and oils. If
skin irritation develops and persists or recurs, get medical attention.
INHALATION:
If symptoms of lung irritation occur (coughing, wheezing or breathing
difficulty), remove from exposure area to fresh air immediately. If
breathing has stopped perform emergency resuscitation. Keep
affected person warm and at rest. Do not leave person unattended.
Get medical attention.
INGESTION:
While there are no known specific effects, if swallowed, and person is
Revision Date: June 2, 2017
Neutralite SR Page 3 of 10
4.
conscious, immediately give person large amounts of water. Get
medical attention. Never give anything by mouth to an unconscious
or convulsing person. Induce vomiting only if instructed by a
physician. If spontaneous vomiting occurs, keep head below hips to
avoid aspiration into lungs.
FIRST AID MEASURES (CONT’D)
NOTE TO PHYSICIANS
5.
None known. Use general supportive care.
FIRE FIGHTING MEASURES
UNUSUAL FIRE AND
EXPLOSION HAZARDS:
None
EXTINGUISHING MEDIA:
None required. Will not support combustion. Proceed in accordance
for surrounding products and hazards.
PROTECTION OF
FIREFIGHTERS:
As in any fire, firefighters must wear approved positive pressure selfcontained breathing apparatus with full face mask (e.g.,
NIOSH/MSHA-approved) and full protective clothing.
6.
ACCIDENTAL RELEASE MEASURES
See Section 8 for Personal Protection measures. Sweep up spilled material and transfer to a suitable
container for disposal or reuse. If product is not contaminated with foreign materials, it may be used as
initially intended.
Waste Disposal: See Section 13 for Disposal Considerations.
7.
HANDLING AND STORAGE
HANDLING:
Avoid contact with eyes, skin and mucous membranes. Avoid generating airborne
dust. Do not breathe dust and control through engineering means if at all possible
(ventilation). Ground all equipment to prevent static discharge. Practice personal
hygiene. Remove contaminated clothing and clean before reuse. Wash thoroughly
after work using soap and water after contact with the material and prior to eating,
drinking, or using tobacco products or applying cosmetics.
STORAGE:
Store in original containers in a cool, well ventilated and secure place. Keep container
tightly closed in a dry area away from moisture. Ground all equipment to prevent static
discharge.
8.
EXPOSURE CONTROLS / PERSONAL PROTECTION
Occupational Exposure Limits:
Particles Not Otherwise Specified- 3 mg/m3 TWA (respirable particles); 10 mg/m3
ACGIH:
TWA (inhalable particles)
OSHA:
Particulate Not Otherwise Classified- 50 mppcf or 15 mg/m3 TWA (total dust); 15
mppcf or 5 mg/m3 TWA (respirable fraction)
MALAYSIA:
5 mg/m3 TWA (containing <1% of free silica, respirable dust); 10 mg/m3 TWA
Revision Date: June 2, 2017
Neutralite SR Page 4 of 10
RUSSIA:
8.
(containing <1% of free silica, total dust)
4 mg/m3 TWA (aerosol)
EXPOSURE CONTROLS / PERSONAL PROTECTION (CONT’D)
ENGINEERING CONTROLS:
Provide local exhaust ventilation to maintain exposure levels
below the occupational exposure limits.
EYE / FACE PROTECTION:
Chemical splash goggles or safety glasses should be worn. Use
of contact lenses with this product is not recommended. Clean
water should be available in work area for flushing eyes.
SKIN PROTECTION:
The use of gloves is optional. Cotton or leather gloves will help
prevent possible dryness associated with contact. Avoid using
wet gloves. Wash hands thoroughly after handling, especially
before eating, drinking or smoking. Clean water should be
available in work area for washing exposed skin. Barrier creams
may be used to prevent dryness and irritation of skin.
RESPIRATORY
PROTECTION:
If exposure limits are exceeded or respiratory irritation is
experienced, NIOSH/MSHA approved respiratory protection
should be worn. Respiratory protection must be provided in
accordance with local regulations (e.g., OSHA 29 CFR 1910.134;
CSA Standard Z94.4-M1982).
GENERAL HYGIENE
CONSIDERATIONS:
9.
Generation of airborne dusts should be kept to a minimum.
PHYSICAL AND CHEMICAL PROPERTIES
Property
Value
Property
Value
Appearance:
White, inert, finely
divided amorphous
innocuous powder
Flammability:
N/A
Odor:
No discernible odor
Upper Explosive Limit:
N/A
Odor Threshold:
Not determined
Lower Explosive Limit:
N/A
pH:
N/A
Vapor Pressure (mm Hg):
N/A
Melting Point:
2400 °F/1317 °C
Specific Gravity (water = 1):
2.3
Initial Boiling Point: N/A
Boiling Range:
N/A
Solubility in Water:
>12.5 mg/L
Vapor Density:
N/A
Partition Coefficient: noctanol/water:
No data
Flash Point:
N/A
Auto-Ignition Temperature:
N/A
Evaporation Rate:
N/A
No data
Decomposition Temperature:
No data
Volatile by Volume
0.00%
Viscosity:
10.
STABILITY AND REACTIVITY
Revision Date: June 2, 2017
Neutralite SR Page 5 of 10
STABILITY:
Stable
CONDITIONS TO AVOID:
None known.
MATERIALS TO AVOID:
Strong acids, strong bases, and mineral acids.
10.
STABILITY AND REACTIVITY (CONT’D)
HAZARDOUS
DECOMPOSITION
PRODUCTS:
HAZARDOUS
POLYMERIZATION:
11.
Will not occur/none identified
Will not occur
TOXICOLOGICAL INFORMATION
POTENTIAL EXPOSURE
ROUTES:
This product may be encountered through skin contact, eye contact,
ingestion, or inhalation of dusts, fumes or powder.
SIGNS AND SYMPTOMS
OF EXPOSURE:
May cause eye, skin and respiratory tract irritation. May cause
gastrointestinal mucosal irritation. Long-term exposure may cause
drying and cracking of the skin or dermatitis, conjunctivitis, or irritation of
tissues and mucous membranes of the respiratory system.
ACUTE TOXICITY:
No data were identified for this product as a whole. Data are for
constituents of the complex alumino-silicates:
Oral LD50 > 2000 mg/kg bw (rat); 8500 mg/kg bw (rat)
Inhalation LC50 > 2.1 mg/L (4-hours, rat)
SERIOUS EYE
DAMAGE/IRRITATION:
SKIN
CORROSION/IRRITATION:
Revision Date: June 2, 2017
No data were identified for this product as a whole. Data are for
constituents of the complex alumino-silicates: In an eye irritation study
performed according to the Organisation for Economic Co-operation and
Development (OECD) Testing guideline (TG) 405, 0.1 mL of material
was instilled into the conjunctival sac of one eye on each of three
rabbits. Eyes were not rinsed following application. Redness, chemosis
and discharge of the conjunctivae was observed in all three rabbits;
however, these effects had completely resolved within 72 hours in all
animals. The overall conclusion was that this ingredient was not irritating
under the conditions of this test.
No data were identified for this product as a whole. Data are for
constituents of the complex alumino-silicates: Two in vitro skin irritation
studies, performed according to OECD TG 431 and EC Regulation No.
Guideline B.46, and testing human skin models, are available for this
proprietary ingredient. Neither study found this ingredient to be irritating
to the human skin models (as measured by a reduction in the viability of
skin cells in the models.
Neutralite SR Page 6 of 10
RESPIRATORY OR SKIN
SENSITIZATION:
No data were identified for this product as a whole. Data are for
constituents of the complex alumino-silicates and yielded mixed results:
In a guinea pig maximization test (GPMT) performed according to OECD
TG 406, material was administered to ten guinea pigs via intradermal
injection and challenge doses were applied 20 days later via topical
application. The percentage of animals sensitized was zero; therefore,
this ingredient was not sensitizing under the conditions of this study. In a
mouse local lymph node assay (LLNA) performed according to OECD
TG 429, three groups of five female mice were treated with this
ingredient via topical application to the ears. Draining lymph nodes were
excised and examined for signs of sensitization. Under the conditions of
this test, this ingredient was found to be sensitizing.
STOT-SINGLE
EXPOSURE:
No data were identified for this product as a whole or its constituents.
STOT-REPEAT
EXPOSURE:
No data were identified for this product as a whole. Data are for
constituents of the complex alumino-silicates: A combined repeated
dose toxicity and reproduction / developmental screening test performed
according to OECD TG 422 on male and female rates did not yield any
toxicologically relevant changes. The No-Observed-Adverse-EffectLevel (NOAEL) is ≥ 1000 mg/kg bw/day.
A 28-week dietary study on mice showed no toxicology significant
effects (NOAEL of ca. ≥ 32 g/kg bw/d). Another study showed moderate
to severe pathological changes to the guinea pig lung following
inhalation exposure for 24 weeks. However the concentration tested was
outside the criteria necessary for classification.
CARCINOGENICITY:
No data were identified for this product as a whole. It is not listed as a
carcinogen by NTP, IARC, or OSHA. Data are for constituents of the
complex alumino-silicates: After oral administration to rats, one of the
proprietary ingredients was able to decrease the number of colon tumors
induced by a known carcinogen.
A 28-week dietary study is available for another proprietary ingredient. In
this study, groups of 21 male and 21 female mice were administered
proprietary ingredient #2 powder continuously in the diet at
concentrations of 0, 1, 10 or 20% (ca. 1.6, 16 and 32 g/kg bw/day). No
neoplasia or hyperplasia of organs/tissues was reported upon gross or
histopathological examinations performed after 14 and 28 weeks of
dosing.
Revision Date: June 2, 2017
Neutralite SR Page 7 of 10
GERM CELL
MUTAGENICITY:
No data were identified for this product as a whole. Data are for
constituents of the complex alumino-silicates: There are no in vivo
studies available; however, three in vitro guideline studies are available
investigating either bacterial or somatic cells. In a bacterial reverse
mutation assay (Ames assay) performed according to OECD TG 471, no
evidence of mutagenicity was observed when the Salmonella
typhimurium and Escherichia coli were treated with this ingredient up to
5000 µg/plate both with and without metabolic activation. In a
mammalian cell gene mutation assay (MGMA) performed according to
OECD TG 476, this ingredient was negative for inducing mutations in
mouse lymphoma cells both with and without metabolic activation. No
evidence of chromosome aberrations was observed in a chromosome
aberration assay performed according to OECD TG 473. In this study,
human lymphocytes were treated with this ingredient both with and
without metabolic activation at concentrations up to 100 µg/mL.
REPRODUCTIVE
TOXICITY EFFECTS:
No data were identified for this product as a whole. Data are for
constituents of the complex alumino-silicates: A combined repeated
dose toxicity and reproduction / developmental screening test performed
according to OECD TG 422 were performed on rats and no reproductive
/ developmental toxicity was observed at any dose level; therefore, both
the reproductive/developmental NOAEL is ≥ 1000 mg/kg bw/day.
A 28-week dietary study is available for mice in which powder was
administered continuously in the diet at concentrations of 0, 1, 10 or
20% (ca. 1.6, 16 and 32 g/kg bw/day). After 14 weeks of dosing, a
decrease in the ovary weight of females in the 1, 10 and 20% groups
was observed; however, this effect fully resolved by 28 weeks.
Histopathological examination of the testes and ovaries did not reveal
any treatment-related changes. Therefore, under the conditions of this
test, the reproductive NOAEC is 20% in the diet (corresponding to a
NOAEL of ca. ≥ 32 g/kg bw/d).
ASPIRATION HAZARD:
INTERACTIONS WITH
OTHER CHEMICALS
WHICH ENHANCE
TOXICITY:
12.
Not relevant. Physical form of solid powder indicates no aspiration
hazard potential.
None known.
ECOLOGICAL INFORMATION
ECOTOXICITY:
No data were identified for this product as a whole. Data are for constituents of
the complex alumino-silicates:
LC50 (96-h, Oncorhynchus mykiss) = 775.8 mg/L; LC50 (96-h, Pimephales
promelas) = 306.79 mg/L
LC50 (48-hours, Daphnia magna) = ca. 170.86 mg/L
EC50 (72-hours, green algae) > 100 mg/L
EC50 (3-hours, activated sludge) > 100 mg/L
MOBILITY:
No data were identified for this product as a whole. The ingredients of this
product are highly water insoluble and have a negligible vapor pressure;
therefore, this product is highly immobile in the environment.
Revision Date: June 2, 2017
Neutralite SR Page 8 of 10
PERSISTENCE/
DEGRADABILITY:
No data were identified for this product as a whole. The ingredients of this
product are not degradable and will persist in the environment.
BIOACCUMULATION No data were identified for this product as a whole or its constituents.
:
NOTE:
This product is generally considered chemically inert in the environment. Used
material which has become contaminated may have significantly different
characteristics based on the contaminant and should be evaluated accordingly.
13. DISPOSAL CONSIDERATIONS
Dispose in accordance with all local, regional, national, or international regulations. This product is not
regulated by RCRA as a hazardous waste.
14.
TRANSPORT INFORMATION
DOT/ADR/RID/IATA:
15.
Not regulated
REGULATORY INFORMATION
U.S. SARA 313 LISTING:
None
U.S. SARA 312 HAZARD
CLASS:
Immediate Health, Delayed Health
U.S. SARA EXTREMELY
HAZARDOUS SUBSTANCES:
None
U.S. EPA HAZARDOUS
SUBSTANCES LIST:
None
U.S. CLEAN WATER ACT:
None
U.S. CLEAN AIR ACT:
None
U.S. TSCA INVENTORY:
All ingredients are either listed on or exempt from listing on the TSCA
Inventory.
U.S. CERCLA:
Not regulated
OSHA HAZARD
COMMUNICATION:
This material is considered hazardous by the OSHA Hazard
Communication Standard (29 CFR 1910.1200).
WHMIS REGULATIONS:
Not controlled
CALIFORNIA PROPOSITION
65:
This product complies with the MSDS and labeling requirements of
the Safe Drinking Water and Toxic Enforcement Act of 1986 (Prop
65).
Revision Date: June 2, 2017
Neutralite SR Page 9 of 10
PENNSYLVANIA WORKER
AND COMMUNITY RIGHT TO
KNOW LAW:
The specific chemical identity of some of the non-hazardous
components are being withheld has a trade secret.
OTHER CHEMICAL
INVENTORIES:
This product is in compliance with chemical inventory requirements
for:
• Australia (AICS)
• Canada (DSL)
• China (IECSC)
• Korea (KECI/KECL)
• New Zealand (NZIoC)
• Philippines (PICCS)
SUPPLEMENTARY
INFORMATION:
This product has been classified by the FDA as GRAS and approved
for use in FDA regulated facilities
16.
OTHER INFORMATION
ABBREVIATIONS: ACGIH:
ADR:
°C
CAS:
CERCLA:
CFR:
CLP:
CSA:
DOT:
EPA:
°F
FDA:
g
GHS:
GRAS:
HMIS:
IARC:
IATA:
kg:
L
LC50:
LD50:
m3
mg
mg/kg bw:
MGMA:
mL:
mm Hg:
mppcf:
SDS:
MSHA:
NFPA:
NIOSH:
NOAEC:
Revision Date: June 2, 2017
American Conference of Governmental Industrial Hygienists
Regulations on the International Carriage of Goods by Road
Degrees Celsius
Chemical Abstract Service Registry
Comprehensive Environmental Response, Compensation, and
Liability Act (U.S.)
Code of Federal Regulations (U.S.)
Classification, Labelling and Packaging Directive
Canadian Standards Association
Department of Transportation (U.S.)
Environmental Protection Agency (U.S.)
Degrees Fahrenheit
Food and Drug Administration (U.S.)
Gram(s)
Globally Harmonized System of Classification and Labelling of
Chemicals
Generally Recognized as Safe
Hazardous Materials Information System
International Agency for Research on Cancer
International Air Transport Association
Kilogram(s)
‘Liter(s)
Lethal Concentration 50%
Lethal Dose 50%
Cubic meter(s)
Milligram(s)
Milligram(s) per kilogram(s) bodyweight
Mammalian Cell Gene Mutation Assay
Milliliter(s)
Millimeter(s) of Mercury
Million Particles Per Cubic Foot
Safety Data Sheet
Mine Safety and Health Administration (U.S.)
National Fire Protection Association (U.S.)
National Institute for Occupational Safety and Health (U.S.)
No-Observed-Adverse-Effect-Concentration
Neutralite SR Page 10 of 10
NOAEL:
NTP:
OECD:
OSHA:
RCRA:
RID:
SARA:
STOT:
TG:
TSCA:
TWA:
µg:
UN:
WHMIS:
No-Observed-Adverse-Effect-Level
National Toxicology Program (U.S.)
Organisation for Economic Co-operation and Development (EU)
Occupational Safety and Health Administration (U.S.)
Resource Conservation and Recovery Act (U.S.)
Regulations on the International Carriage of Goods by Rail
Superfund Amendments and Reauthorization Act (U.S.)
Specific Target Organ Toxicity
Testing Guideline
Toxic Substances Control Act (U.S.)
Time Weighted Average
Microgram(s)
United Nations
Workplace Hazardous Material Information System (Canada)
PRECAUTIONA
RY
STATEMENTS:
Prevention
None
Response
None
HMIS Ratings
Health: 0
REVISIONS:
Revised sections 2, 11, 12, 15 and 16 of this SDS on June 2, 2017 to conform to
Regulation (EC) No 1272/2008 and Regulation (EC) No 1907/2006 Standards.
PREPARED BY:
ARCADIS, using standard references and information provided and directed.
NOTICE:
The users of this product need to study this safety data sheet (SDS) and
become aware of product hazards and safety information. To promote safe
use of this product, a user should (1) notify its employees, agents, and
contractors of the information on this SDS and any product hazard and safety
information, (2) furnish this same information to each of its customers for the
product and (3) request such customers to notify their employees and
customers of the product hazards and safety information.
Flammability: 0
Storage
None
Disposal
None
Reactivity: 0
The opinions expressed herein are those of qualified experts within. We
believe that the information contained herein is current as of the date of this
SDS. Since the use of this product is not within the control of, it is the user’s
obligation to determine the conditions of safe use of this product.
Revision Date: June 2, 2017